Congo to use Ebola vaccine to counter flare-up

Four people have tested positive for Ebola


Democratic Republic of Congo (DRC) officials say they will start using Ebola vaccine to counter a flare-up in the heavily populated eastern part of the Central African country, according to an article on the Reuters website.

Four people have tested positive for Ebola in and around Mangina, a town of about 60,000 people in North Kivu province, about 60 miles) from the Ugandan border.  

Another 20 people died from unidentified hemorrhagic fevers in July. The World Health Organization (WHO) declared the ninth outbreak of Ebola in the Democratic Republic of the Congo (DRC) over on July 24, according to an article on WHO website. 

Unlike previous DRC Ebola outbreaks, this one involved four locations, including an urban center with river connections to the capital and to neighboring countries, as well as remote rainforest villages.

Read the article.

 

 



August 7, 2018


Topic Area: Infection Control


Recent Posts

Mattresses Require Strict Care to Prevent Spread of Infections

Poor cleaning and disinfection techniques contribute to the persistent contamination of patient mattresses.


Gardner Health Services Opens Alum Rock Health Center

The 10,080-square-foot facility provides essential medical, dental, mental and chiropractic services to the Mayfair and East San José neighborhoods.


The Children's Center of Hamden Reports Data Security Incident

The incident was detected on December 28, 2024.


Designing for Senior Care Communities Means Designing for Everyone

No spaces can be designed for just one person, designers need to think about everyone who will occupy the space.


Harlem Hospital Legionnaires' Outbreak Highlights Cooling Tower Risks

Seven deaths linked to the cooling towers underscore the need for stricter water system monitoring and preventive maintenance in healthcare settings.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.